← Back to all trials
Not Yet Recruiting
NCT05739877
Phamacokinetics and Safety Profiles of DA-1229_01 2.5/500mg in Healthy Subjects at Fed State
Conditions: Healthy
Sex: All
Ages: 19 Years – N/A
Healthy volunteers: 1
Phase: PHASE1
Enrollment: 34
Sponsor: Dong-A ST Co., Ltd.
Location: Korea, Republic of
Summary
This Phase I clinical study is to evaluate the safety/tolerability and pharmacokinetics of DA-1229_01(2.5/500
mg x1 tablets) at fed state
Eligibility Criteria
Inclusion Criteria:Healthy VolunteersBMI between 18 and 30 kg/m2Body weight : Male≥50kg, Female≥45kgExclusion Criteria:Allergy or Drug hypersensitivityClinically significant Medical History
Source: ClinicalTrials.gov (NCT05739877). StuddyBuddy aggregates publicly available trial information.
